Skip to main content
. 2011 Jun 8;2012:190708. doi: 10.1155/2012/190708

Table 3.

Median 3-year-survival (IQR) of patients with cholangiocarcinoma undergoing stand-alone chemotherapy versus combination of chemotherapy and interventional therapies (palliation group).

Therapy Total (n) Median survival (months) significance (P)
Chemo + PDT 11 16.3 (10.9)
Chemo 84 14.5 (16.9) .283
Chemo + TACE 14 22.0 (10)
Chemo 81 12.2(16.6) .039